Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Jade Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:11 pm Purchase | 2025-12-31 | 13G | JADE BIOSCIENCES, INC. JBIO | Venrock Healthcare Capital Partners III, L.P. | 5,115,862 9.900% | 1,895,493 (+58.86%) | Filing |
| 2025-05-05 4:26 pm Purchase | 2025-04-28 | 13G | JADE BIOSCIENCES, INC. JBIO | Venrock Healthcare Capital Partners III, L.P. | 3,220,369 9.900% | 3,220,369 (New Position) | Filing |